Urologix, Inc.
http://www.urologix.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Urologix, Inc.
Takeda Uses AcuraStem Deal To Bolster Neuro Pipeline, Move Into ALS
Deal Snapshot: Looking to add to its neuroscience pipeline, Takeda acquires rights to the antisense candidate AS-202 from AcuraStem for development as a potential amyotrophic lateral sclerosis therapy.
Korean COVID-19 Contenders Still Racing Toward Finish Line
Hyundai Bioscience’s niclosamide-based oral antiviral moves into Phase II, joining other Korean COVID-19 treatment candidates in the pivotal trial stages, while SK Bioscience’s Phase III recombinant protein vaccine gears up for global market entry.
Korean Pharmas Seek Tie-Ups, Support To Enter Pharmerging Markets
Through its latest government-linked project, Korean pharma consortium Kimco aims to speed up industry collaboration and step up technology competitiveness to move into rapidly growing pharmerging markets.
Medtech Execs On The Move, April 2015
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Company Information
- Industry
-
Medical Devices
- Radiofrequency Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice